Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy

Completed · Phase 4

Conditions studied: Diabetic Neuropathy, Painful

In brief

The purposes of this study are to: 1) find out if pregabalin relieves pain in subjects with painful diabetic peripheral neuropathy; 2) find out if pregabalin is safe at a dose of 600 mg/day (taken twice a day); and 3) find out if changes in nerve function happen during the study.

Key facts

Study ID

NCT00159679

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

167

Starts

2004-09-01

Expected to finish

2005-10-01

Last updated by the study team

2021-01-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults with Type 1 or 2 diabetes
• Patients must have pain in their lower legs or feet due to painful diabetic neuropathy that has lasted for at least 3 months

You may not qualify if…

• Patients must not be in poor or unstable health.

Where it is running

• Pfizer Investigational Site — Hot Springs, Arkansas, United States
• Pfizer Investigational Site — La Jolla, California, United States
• Pfizer Investigational Site — Torrance, California, United States
• Pfizer Investigational Site — Torrance, California, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Lake Worth, Florida, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — Palm Beach Gardens, Florida, United States
• Pfizer Investigational Site — Sunrise, Florida, United States
• Pfizer Investigational Site — West Palm Beach, Florida, United States
• Pfizer Investigational Site — West Palm Beach, Florida, United States
• Pfizer Investigational Site — Boston, Massachusetts, United States
• Pfizer Investigational Site — Omaha, Nebraska, United States
• Pfizer Investigational Site — Omaha, Nebraska, United States
• Pfizer Investigational Site — Las Vegas, Nevada, United States
• Pfizer Investigational Site — Englewood, New Jersey, United States
• Pfizer Investigational Site — New Brunswick, New Jersey, United States
• Pfizer Investigational Site — New Brunswick, New Jersey, United States
• Pfizer Investigational Site — Albany, New York, United States
• Pfizer Investigational Site — Rochester, New York, United States
• Pfizer Investigational Site — Rochester, New York, United States
• Pfizer Investigational Site — Greenville, North Carolina, United States
• Pfizer Investigational Site — Toledo, Ohio, United States
• Pfizer Investigational Site — Duncansville, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.